Respiratory Distress Syndrome
📧 Sign up to get email alerts when something new happens for Respiratory Distress Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-07-12Clinical Trial Update: Mineralocorticoid Use in COVID-19 Patients [Phase 3]
Phase 3 clinical trial update on mineralocorticoid use in COVID-19 patients, completed.
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19 [Phase 2]
A Phase II clinical trial update for a treatment in patients with moderate to severe ARDS due to COVID-19.
-
CLINICAL_TRIALS trial_result · 2022-07-06Clinical Trial Update: Effect of Bronchoscopy on the Outcome of Patients With Severe Sepsis With ARDS and Complicated by VAP From Prolonged Ventilation [Phase 1, Phase 2]
Clinical trial update reporting completed Phase 1/2 study on bronchoscopy impact in patients with severe sepsis and ARDS complicated by VAP …
-
CLINICAL_TRIALS trial_result · 2022-06-29Clinical Trial Update: Losartan for Patients With COVID-19 Requiring Hospitalization [Phase 2]
A Phase 2 clinical trial evaluating losartan for hospitalized COVID-19 patients has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2022-05-31Clinical Trial Update: Inhaled Steroids for the Treatment of Early Pediatric Acute Respiratory Distress Syndrome [Phase 2]
Phase 2 trial evaluating inhaled steroids for early pediatric acute respiratory distress syndrome was terminated; results posted in 2022.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-05-24Clinical Trial Update: Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia [Phase 3]
Phase 3 trial of IV ravulizumab in COVID-19 severe pneumonia was terminated; results posted but no ongoing study.
-
CLINICAL_TRIALS trial_result · 2022-05-17Clinical Trial Update: Diaphragm Ultrasound Vs Transpulmonary Pressure To Set PEEP in ARDS [NA]
Completed clinical trial comparing diaphragm ultrasound versus transpulmonary pressure to guide PEEP in ARDS; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: Using GM-CSF as a Host Directed Therapeutic Against COVID-19 [Phase 2]
Phase 2 trial update evaluating GM-CSF as a host-directed therapy for COVID-19 completed.
-
CLINICAL_TRIALS trial_result · 2022-05-09Clinical Trial Update: Clinical Trial of Efficacy and Safety of Oral Drug in Adult Patients With COVID-19 [Phase 1, Phase 2]
Clinical trial update for an oral drug in adults with COVID-19 across Phase 1 and Phase 2 investigating efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2022-05-04Clinical Trial Update: Losartan for Patients With COVID-19 Not Requiring Hospitalization [Phase 2]
Phase 2 trial update examining losartan for non-hospitalized COVID-19 patients; study completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: MSCs in COVID-19 ARDS [Phase 3]
Phase 3 trial of mesenchymal stromal cells (Remestemcel-L) for COVID-19–related ARDS appears terminated.
-
CLINICAL_TRIALS trial_result · 2022-04-19Clinical Trial Update: Fenofibrate for Patients With COVID-19 Requiring Hospitalization [Phase 3]
Phase 3 trial update for fenofibrate in hospitalized COVID-19 patients, status currently unknown.
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: Effect of Arterio-venous ECMO on Severe Sepsis and ARDS [Phase 1, Phase 2]
A phase 1/2 trial evaluating the effect of arterio-venous ECMO on severe sepsis and ARDS has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-11Clinical Trial Update: Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress [Phase 2]
Phase 2 study investigating allogeneic adipose-derived mesenchymal stem cells for treating COVID-19 acute respiratory distress; status uncle…
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS) [NA]
Clinical trial update on prolonged prone positioning for COVID-19–induced ARDS has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: Inhaled Iloprost for Suspected COVID-19 Respiratory Failure [Phase 2]
Phase 2 trial evaluating inhaled iloprost for suspected COVID-19 respiratory failure has completed.
-
CLINICAL_TRIALS trial_result · 2022-03-23Clinical Trial Update: A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19 [Phase 1, Phase 2]
Clinical trial updates for APL-9 in adults with mild to moderate ARDS due to COVID-19 have completed Phase 1 and Phase 2; results posted in …
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: Tolerability and Efficacy of RJX in Patients With COVID-19 [Phase 1, Phase 2]
Clinical trial update for RJX in COVID-19 patients reports tolerability and efficacy data across Phase 1 and Phase 2, with ongoing status.
-
CLINICAL_TRIALS trial_result · 2022-03-11Clinical Trial Update: The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19 [Phase 1, Phase 2]
Clinical trial update on using exosomes for acute respiratory distress syndrome or COVID-19 related pneumonia (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2022-03-04Clinical Trial Update: Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury [Phase 2]
Phase 2 clinical trial evaluating CERC-002 for adults with COVID-19 pneumonia and acute lung injury has completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-02-28Clinical Trial Update: Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Disease [Phase 1, Phase 2]
A safety-focused clinical trial update on nebulized BromAc® therapy for COVID-19-related respiratory conditions across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2022-02-18Clinical Trial Update: Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS [Phase 1, Phase 2]
Clinical trial update on using umbilical cord-derived mesenchymal stromal cells for SARS-CoV-2-related ARDS, completed phases 1 and 2.
-
CLINICAL_TRIALS trial_result · 2022-02-15Clinical Trial Update: MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients [Phase 2]
Phase 2 trial update for MRG-001, exploring immunoregulatory and regenerative therapy for COVID-19 patients, including ARDS.
-
CLINICAL_TRIALS trial_result · 2022-01-27Clinical Trial Update: Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS) [Phase 2]
Phase 2 trial investigating mesenchymal stem cells in inflammation-resolution for COVID-19–induced ARDS. Current status is unknown.
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19 [Phase 2]
A Phase 2 trial evaluating immunomodulation with naltrexone and ketamine for COVID-19 was terminated; results were posted in 2022.